News

The FDA says it will use artificial intelligence to expedite the approval of new drugs and devices. Investigators with the ...
The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be ...
Digital transformation in healthcare accelerates adoption of AI-enabled monitoring solutions across global marketsDelray ...
There is an immediate need for a new, agile process that helps everyday people find safe and trustworthy mental health AI ...
The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...
Walmart recalls shrimp in 13 states after FDA finds radioactive contamination. OpenAI challenger Manus hits $90M revenue run ...
Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.
Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...
The rally in the market came as the approval made PAPZIMEOS the first and only FDA-approved therapy for adult RRP patients.
Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.
ORLANDO, FLORIDA / ACCESS Newswire / August 19, 2025 / RedChip Companies, an international investor relations, media, and ...
As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...